H. B. Fuller Company
FUL Basic Materials Specialty Chemicals
H. B. Fuller Company’s revenue for fiscal 2025 (year ended November 2025) was $3.5 billion, down 2.67% from fiscal 2024.
- Revenue
- +5.17%
- EPS
- +18.2%
- Free cash flow
- −58.4%
- Total debt
- −1.25%
Quarter to August 2026, against a year earlier
Follow FUL
Alert me
H. B. Fuller Company (FUL) EBITDA
H. B. Fuller Company's EBITDA for fiscal 2025 was $533.4M, unchanged from fiscal 2024. Over the twelve months to 31 August 2026 it was $564.5M. Over the past ten years it has ranged from $206.8M (fiscal 2017) to $533.4M (fiscal 2025) — the current reading is the highest in ten years. EBITDA has risen for 5 consecutive fiscal years. H. B. Fuller Company ranks 20th of 59 Specialty Chemicals companies by EBITDA.
EBITDA, annual
Embed this chart
Annual newest first
| Period | EBITDA | Change |
|---|---|---|
| FY2025 | $533.4M | 2.00% |
| FY2024 | $522.9M | 1.54% |
| FY2023 | $515.0M | 9.64% |
| FY2022 | $469.7M | 18.67% |
| FY2021 | $395.8M | 10.82% |
| FY2020 | $357.1M | (2.74%) |
| FY2019 | $367.2M | (4.13%) |
| FY2018 | $383.0M | 85.17% |
| FY2017 | $206.8M | (25.02%) |
| FY2016 | $275.9M | 12.24% |
Quarterly newest first
| Period | EBITDA | Change |
|---|---|---|
| Aug 2026 | $159.2M | (2.51%) |
| May 2026 | $163.3M | 66.74% |
| Feb 2026 | $98.0M | (31.93%) |
| Nov 2025 | $143.9M | (7.57%) |
| 43 more quarters | Free account |
Against its own ten years
EBITDA against peers
| Company | EBITDA |
|---|---|
| CBT Cabot Corporation compare | $673.0M |
| FUL H. B. Fuller Company | $564.5M |
| ASH Ashland Inc. compare | $336.0M |
| KWR Quaker Houghton compare | $255.7M |
| NGVT Ingevity Corporation compare | $237.9M |
| CC The Chemours Company compare | $217.0M |
| HWKN Hawkins, Inc. compare | $181.8M |
| CLMT Calumet, Inc. compare | $133.9M |
| WDFC WD-40 Company compare | $119.3M |
What EBITDA is
EBITDA shows what a company earns from its operations before interest, taxes and the non-cash charges for depreciation and amortization.
Reported line item
More on FUL
- Revenue
- Net income
- EPS (diluted)
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement